Strategies for improving mucosal drug delivery

Nanomedicine

Volumn 8, Issue 12, 2013, Pages 2061-2075

  Laffleur, Flavia ^a   Bernkop Schnürch, Andreas ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

mucoadhesion; mucosal membrane; mucus; mucus penetration; nanodelivery; self emulsifying drug delivery system

Indexed keywords

DRUG DELIVERY SYSTEM; DRUG RELEASE; EPITHELIUM; MEMBRANE PERMEABILITY; MUCOSA; MUCOSAL DRUG DELIVERY SYSTEM; PRIORITY JOURNAL; REVIEW;

ADMINISTRATION, MUCOSAL; ANIMALS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; MUCOUS MEMBRANE; PHARMACEUTICAL PREPARATIONS; POLYMERS;

EID: 84889585887     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.13.178     Document Type: Review

References (100)

1. Kammona O, Kiparissides C. Recent advances in nanocarrier-based mucosal delivery of biomolecules. J. Control. Release 161(3), 781-794 (2012
2. Bernkop Schnürch A, Dünnhaupt S. Chitosan-based drug delivery systems. Eur. J. Pharm. Biopharm. 81(3), 463-469 (2012
3. Chadwick S, Kriegel C, Amiji M. Nanotechnology solutions for mucosal immunization. Adv. Drug Deliv. Rev. 62(4-5), 394-407 (2010
4. Chaudhury A, Das S. Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents. AAPS PharmSciTech 12(1), 10-20 (2011
5. Brayden DJ, Mrsny RJ. Oral peptide delivery: Prioritizing the leading technologies. Ther. Deliv. 2(12), 1567-1573 (2011
6. Barthelmes J, Dünnhaupt S, Hombach J, Bernkop Schnürch A. Thiomer nanoparticles: Stabilization via covalent crosslinking. Drug Deliv. 18(8), 613-619 (2011
7. Naahidi S, Jafari M, Edalat F, Raymond K, Khademhosseini A, Chen P. Biocompatibility of engineered nanoparticles for drug delivery. J. Control. Release 166(2), 182-194 (2013
8. Collnot EM, Ali H, Lehr CM. Nano-And microparticulate drug carriers for targeting of the inflamed intestinal mucosa. J. Control. Release 161(2), 235-246 (2012
9. Chen MC, Sonaje K, Chen KJ, Sung HW. A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery. Biomaterials 32(36), 9826-9838 (2011
10. Yan L, Yang C, Tang J. Disruption of the intestinal mucosal barrier in Candida albicans infections. Microbiol. Res. 168(7), 389-395 (2013
11. Sudhakar Y, Kuotsu K, Bandyopadhyay AK. Buccal bioadhesive drug delivery-A promising option for orally less efficient drugs. J. Control. Release 114(1), 15-40 (2006 (Pubitemid 44128620)
12. McNairn AJ, Guasch G. Epithelial transition zones: Merging microenvironments, niches, and cellular transformation. Eur. J. Dermatol. 21(Suppl. 2), S21-S28 (2011
13. Khutoryanskiy VV. Advances in mucoadhesion and mucoadhesive polymers. Macromol. Biosci. 11(6), 748-764 (2011
14. Woodrow KA, Bennett KM, Lo DD. Mucosal vaccine design and delivery. Annu. Rev. Biomed. Eng. 14, 17-46 (2012
15. Hall DJ, Khutoryanskaya OV, Khutoryanskiy VV. Developing synthetic mucosa-mimetic hydrogels to replace animal experimentation in characterisation of mucoadhesive drug delivery systems. Soft Matter. 7(20), 9620-9623 (2011
16. Zhu Q, Talton J, Zhang G et al. Large intestine-Targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection. Nat. Med. 18(8), 1291-1296 (2012
17. Lawson LB, Norton EB, Clements JD. Defending the mucosa: Adjuvant and carrier formulations for mucosal immunity. Curr. Opin. Immunol. 23(3), 414-420 (2011
18. Shakya P, Madhav NV, Shakya AK, Singh K. Palatal mucosa as a route for systemic drug delivery: A review. J. Control. Release 151(1), 2-9 (2011
19. Bernkop Schnürch A. The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins. J. Control. Release 52(1-2), 1-16 (1998
20. Mao X, Zeng X, Qiao S, Wu G, Li D. Specific roles of threonine in intestinal mucosal integrity and barrier function. Front. Biosci. (Elite Ed.) 3, 1192-1200 (2011
21. Mrsny RJ. Lessons from nature: 'pathogen-mimetic' systems for mucosal nano-medicines. Adv. Drug Deliv. Rev. 61(2), 172-192 (2009
22. Lai SK, Wang YY, Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv. Drug Deliv. Rev. 61(2), 158-171 (2009
23. Ensign LM, Tang BC, Wang YY et al. Mucus penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus. Sci. Transl. Med. 4(138), 138ra79 (2012
24. Muller C, Leithner K, Hauptstein S, Hintzen F, Salvenmoser W, Bernkop Schnürch A. Preparation and characterization of mucus penetrating papain/poly(acrylic acid) nanoparticles for oral drug delivery applications. J. Nanopart. Res. 15(1), 1353 (2013
25. Oh DH, Chun KH, Jeon SO, Kang JW, Lee S. Enhanced transbuccal salmon calcitonin (sCT) delivery: Effect of chemical enhancers and electrical assistance on in vitro sCT buccal permeation. Eur. J. Pharm. Biopharm. 79(2), 357-363 (2011
26. Barthelmes J, Dünnhaupt S, Unterhofer S, Perera G, Schlocker W, Bernkop Schnürch A. Thiolated particles as effective intravesical drug delivery systems for treatment of bladder-related diseases. Nanomedicine (Lond.) 8(1), 65-75 (2013
27. Date AA, Desai N, Dixit R, Nagarsenker M. Self-nanoemulsifying drug delivery systems: Formulation insights, applications and advances. Nanomedicine (Lond.) 5(10), 1595-1616 (2010
28. Qi XL, Wang LS, Zhu JB, Hu ZY, Zhang J. Self-double-emulsifying drug delivery system (SDEDDS): A new way for oral delivery of drugs with high solubility and low permeability. Int. J. Pharm. 409(1-2), 245-251 (2011
29. Kohli K, Chopra S, Dhar D, Arora S, Khar RK. Self-emulsifying drug delivery systems: An approach to enhance oral bioavailability. Drug Discov. Today 15(21-22), 958-965 (2010
30. Ruan JH, Liu J, Zhu D et al. Preparation and evaluation of self-nanoemulsified drug delivery systems (SNEDDSs) of matrine based on drug-phospholipid complex technique. Int. J. Pharm. 386(1-2), 282-290 (2010
31. Liu Z, Zhang X, Li J, Liu R, Shu L, Jin J. Effects of Labrasol on the corneal drug delivery of baicalin. Drug Deliv. 16(7), 399-404 (2009
32. Ganem-Quintanar A, Quintanar-Guerrero D, Falson-Rieg F, Buri P. Ex vivo oral mucosal permeation of lidocaine hydrochloride with sucrose fatty acid esters as absorption enhancers. Int. J. Pharm. 173(1-2), 203-210 (1998 (Pubitemid 29027774)
33. Sek L, Boyd BJ, Charman WN, Porter CJ. Examination of the impact of a range of pluronic surfactants on the in-vitro solubilisation behaviour and oral bioavailability of lipidic formulations of atovaquone. J. Pharm. Pharmacol. 58(6), 809-820 (2006 (Pubitemid 43836167)
34. Nepal PR, Han HK, Choi HY. Preparation and in vitro-in vivo evaluation of Witepsol (R) H35 based self-nanoemulsifying drug delivery systems (SNEDDS) of coenzyme Q(10). Eur. J. Pharm. Sci. 39(4), 224-232 (2010
35. Sakloetsakun D, Perera G, Hombach J, Millotti G, Bernkop Schnürch A. The impact of vehicles on the mucoadhesive properties of orally administrated nanoparticles: A case study with chitosan-4-Thiobutylamidine conjugate. AAPS PharmSciTech 11(3), 1185-1192 (2010
36. Venkatesh G, Majid MI, Mansor SM, Nair NK, Croft SL, Navaratnam V. In vitro and in vivo evaluation of self-microemulsifying drug delivery system of buparvaquone. Drug Dev. Ind. Pharm. 36(6), 735-745 (2010
37. Chitneni M, Peh KK, Darwis Y, Abdulkarim M, Abdullah GZ, Qureshi MJ. Intestinal permeability studies of sulpiride incorporated into self-microemulsifying drug delivery system (Smedds). Pak. J. Pharm. Sci. 24(2), 113-121 (2011
38. Cavalli R, Gasco MR, Chetoni P, Burgalassi S, Saettone MF. Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. Int. J. Pharm. 238(1-2), 241-245 (2002 (Pubitemid 34457892)
39. Primard C, Poecheim J, Heuking S, Sublet E, Esmaeili F, Borchard G. Multifunctional PLGA-based nanoparticles encapsulating simultaneously hydrophilic antigen and hydrophobic immunomodulator for mucosal immunization. Mol. Pharm. 10(8), 2996-3004 (2013
40. Christiansen A, Backensfeld T, Weitschies W. Effects of non-ionic surfactants on in vitro triglyceride digestion and their susceptibility to digestion by pancreatic enzymes. Eur. J. Pharm. Sci. 41(2), 376-382 (2010
41. Takeuchi H, Yamamoto H, Kawashima Y. Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv. Drug Deliv. Rev. 47, 39-54 (2001 (Pubitemid 32209231)
42. Gradauer K, Dünnhaupt S, Vonach C et al. Thiomer-coated liposomes harbor permeation enhancing and efflux pump inhibitory properties. J. Control. Release 165(3), 207-215 (2013
43. Sakloetsakun D, Iqbal J, Millotti G, Vetter A, Bernkop Schnürch A. Thiolated chitosans: Influence of various sulfhydryl ligands on permeation-enhancing and P-gp inhibitory properties. Drug Dev. Ind. Pharm. 37(6), 648-655 (2011
44. Dünnhaupt S, Barthelmes J, Rahmat D et al. S-protected thiolated chitosan for oral delivery of hydrophilic macromolecules: Evaluation of permeation enhancing and efflux pump inhibitory properties. Mol. Pharm. 9(5), 1331-1341 (2012
45. Rahmat D, Sakloetsakun D, Shahnaz G, Sarti F, Laffleur F, Schnürch AB. HEC cysteamine conjugates: Influence of degree of thiolation on efflux pump inhibitory and permeation enhancing properties. Int. J. Pharm. 422(1-2), 40-46 (2012
46. Muller C, Rahmat D, Sarti F, Leithner K, Bernkop Schnürch A. Immobilization of 2-mercaptoethylamine on oxidized chitosan: A substantially mucoadhesive and permeation enhancing polymer. J. Mater. Chem. 22(9), 3899-3908 (2012
47. Irmukhametova GS, Mun GA, Khutoryanskiy VV. Thiolated mucoadhesive and PEGylated nonmucoadhesive organosilica nanoparticles from 3- mercaptopropyltrimethoxysilane. Langmuir 27(15), 9551-9556 (2011
48. Dünnhaupt S, Barthelmes J, Iqbal J et al. In vivo evaluation of an oral drug delivery system for peptides based on S-protected thiolated chitosan. J. Control. Release 160(3), 477-485 (2012
49. Wang XQ, Iqbal J, Rahmat D, Bernkop Schnürch A. Preactivated thiomers: Permeation enhancing properties. Int. J. Pharm. 438(1-2), 217-224 (2012
50. Sarti F, Bernkop Schnürch A. Chitosan and thiolated chitosan. Chitosan Biomater. I 243, 93-110 (2011
51. Garg NK, Mangal S, Khambete H, Tyagi RK. Mucosal delivery of vaccines: Role of mucoadhesive/biodegradable polymers. Recent. Pat. Drug Deliv. Formul. 4(2), 114-128 (2010
52. Barthelmes J, Perera G, Hombach J, Dünnhaupt S, Bernkop Schnürch A. Development of a mucoadhesive nanoparticulate drug delivery system for a targeted drug release in the bladder. Int. J. Pharm. 416(1), 339-345 (2011
53. Laffleur F, Bernkop Schnürch A. Thiomers: Promising platform for macromolecular drug delivery. Future Med. Chem. 4(17), 2205-2216 (2012
54. Millotti G, Hoyer H, Engbersen JFJ, Bernkop Schnürch A. 6-mercaptonicotinamide-functionalized chitosan: A potential excipient for mucoadhesive drug delivery systems. J. Drug Deliv. Sci. Technol. 20(3), 181-186 (2010
55. Peppas NA, Thomas JB, McGinty J. Molecular aspects of mucoadhesive carrier development for drug delivery and improved absorption. J. Biomater. Sci. Polym. Ed. 20(1), 1-20 (2009
56. Jabbari E, Peppas NA. Polymer-polymer interdiffusion and adhesion. J. Macromol. Sci. Revs. Macromol. Chem. Phys. C34(2), 205-241 (1994
57. Peppas NA, Huang Y. Nanoscale technology of mucoadhesive interactions. Adv. Drug Deliv. Rev. 56(11), 1675-1687 (2004 (Pubitemid 39185823)
58. Mangal S, Pawar D, Garg NK et al. Pharmaceutical and immunological evaluation of mucoadhesive nanoparticles based delivery system(s) administered intranasally. Vaccine 29(31), 4953-4962 (2011
59. Mueller C, Verroken A, Iqbal J, Bernkop Schnürch A. Thiolated chitosans: In vitro comparison of mucoadhesive properties. J. Appl. Polym. Sci. 124(6), 5046-5055 (2012
60. King-Smith PE, Fink BA, Hill RM, Koelling KW, Tiffany JM. The thickness of the tear film. Curr. Eye Res. 29(4-5), 357-368 (2004 (Pubitemid 40095021)
61. Holly FJ, Lemp MA. Tear physiology and dry eyes. Surv. Ophthalmol. 22(2), 69-87 (1977 (Pubitemid 8202636)
62. Prydal JI, Artal P, Woon H, Campbell FW. Study of human precorneal tear film thickness and structure using laser interferometry. Invest. Ophth. Vis. Sci. 33(6), 2006-2011 (1992
63. Clunes MT, Boucher RC. Cystic fibrosis: The mechanisms of pathogenesis of an inherited lung disorder. Drug Discov. Today Dis. Mech. 4(2), 63-72 (2007 (Pubitemid 351966331)
64. Tarran R, Grubb BR, Gatzy JT, Davis CW, Boucher RC. The relative roles of passive surface forces and active ion transport in the modulation of airway surface liquid volume and composition. J. Gen. Physiol. 118(2), 223-236 (2001 (Pubitemid 32744527)
65. Matsui H, Grubb BR, Tarran R et al. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 95(7), 1005-1015 (1998 (Pubitemid 29019052)
66. Verkman AS, Song Y, Thiagarajah Jr. Role of airway surface liquid and submucosal glands in cystic fibrosis lung disease. Am. J. Physiol. Cell Physiol. 284(1), C2-C15 (2003 (Pubitemid 35470620)
67. Jordan N, Newton J, Pearson J, Allen A. A novel method for the visualization of the in situ mucus layer in rat and man. Clin. Sci. (Lond.) 95(1), 97-106 (1998 (Pubitemid 28370584)
68. Kerss S, Allen A, Garner A. A simple method for measuring thickness of the mucus gel layer adherent to rat, frog and human gastric mucosa: Influence of feeding, prostaglandin, N-Acetylcysteine and other agents. Clin. Sci. (Lond.) 63(2), 187-195 (1982 (Pubitemid 12000382)
69. van der Waaij LA, Harmsen HJ, Madjipour M et al. Bacterial population analysis of human colon and terminal ileum biopsies with 16S rRNA-based fluorescent probes: Commensal bacteria live in suspension and have no direct contact with epithelial cells. Inflamm. Bowel Dis. 11(10), 865-871 (2005 (Pubitemid 41428844)
70. Matsuo K, Ota H, Akamatsu T, Sugiyama A, Katsuyama T. Histochemistry of the surface mucous gel layer of the human colon. Gut 40(6), 782-789 (1997 (Pubitemid 27305472)
71. Behrens I, Stenberg P, Artursson P, Kissel T. Transport of lipophilic drug molecules in a new mucus-secreting cell culture model based on HT29-MTX cells. Pharm. Res. 18(8), 1138-1145 (2001 (Pubitemid 32900399)
72. Pullan RD, Thomas GA, Rhodes M et al. Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut 35(3), 353-359 (1994 (Pubitemid 24092905)
73. Copeman M, Matuz J, Leonard AJ, Pearson JP, Dettmar PW, Allen A. The gastroduodenal mucus barrier and its role in protection against luminal pepsins: The effect of 16,16 dimethyl prostaglandin E2, carbopol-polyacrylate, sucralfate and bismuth subsalicylate. J. Gastroenterol. Hepatol. 9(Suppl. 1), S55-S59 (1994
74. Atuma C, Strugala V, Allen A, Holm L. The adherent gastrointestinal mucus gel layer: Thickness and physical state in vivo. Am. J. Physiol. Gastrointest. Liver Physiol. 280(5), G922-G929 (2001
75. Strugala V, Allen A, Dettmar PW, Pearson JP. Colonic mucin: Methods of measuring mucus thickness. Proc. Nutr. Soc. 62(1), 237-243 (2003 (Pubitemid 36569835)
76. Szentkuti L, Lorenz K. The thickness of the mucus layer in different segments of the rat intestine. Histochem. J. 27(6), 466-472 (1995
77. Greaves JL, Wilson CG. Treatment of diseases of the eye with mucoadhesive delivery systems. Adv. Drug Deliv. Rev. 11(3), 349-383 (1993 (Pubitemid 23302852)
78. Ali MS, Pearson JP. Upper airway mucin gene expression: A review. Laryngoscope 117(5), 932-938 (2007 (Pubitemid 46699374)
79. Schuhl JF. Nasal mucociliary clearance in perennial rhinitis. J. Investi. Allergol. Clin. Immunol. 5(6), 333-336 (1995 (Pubitemid 26012936)
80. Saketkhoo K, Januszkiewicz A, Sackner MA. Effects of drinking hot water, cold water, and chicken soup on nasal mucus velocity and nasal airflow resistance. Chest 74(4), 408-410 (1978 (Pubitemid 9047790)
81. Mainardes RM, Urban MC, Cinto PO, Chaud MV, Evangelista RC, Gremiao MP. Liposomes and micro/nanoparticles as colloidal carriers for nasal drug delivery. Curr. Drug Deliv. 3(3), 275-285 (2006 (Pubitemid 44031626)
82. Illum L. Nasal drug delivery-possibilities, problems and solutions. J. Control. Release 87(1-3), 187-198 (2003 (Pubitemid 36255456)
83. Mitra AK, Krishnamoorthy R. Prodrugs for nasal drug delivery. Adv. Drug Deliver. Rev. 29(1-2), 135-146 (1998 (Pubitemid 28044090)
84. Wong JW, Keens TG, Wannamaker EM, Crozier DN, Levison H, Aspin N. Effects of gravity on tracheal mucus transport rates in normal subjects and in patients with cystic fibrosis. Pediatrics 60(2), 146-152 (1977 (Pubitemid 8165117)
85. Foster WM, Langenback E, Bergofsky EH. Measurement of tracheal and bronchial mucus velocities in man-relation to lung clearance. J. Appl. Physiol. 48(6), 965-971 (1980 (Pubitemid 10059464)
86. Hofmann W, Asgharian B. The effect of lung structure on mucociliary clearance and particle retention in human and rat lungs. Toxicol. Sci. 73(2), 448-456 (2003 (Pubitemid 36701747)
87. Leikauf G, Yeates DB, Wales KA, Spektor D, Albert RE, Lippmann M. Effects of sulfuric acid aerosol on respiratory mechanics and mucociliary particle clearance in healthy nonsmoking adults. Am. Ind. Hyg. Assoc. J. 42(4), 273-282 (1981 (Pubitemid 11145624)
88. Yeates DB, Aspin N, Levison H, Jones MT, Bryan AC. Mucociliary tracheal transport rates in man. J. Appl. Physiol. 39(3), 487-495 (1975
89. Yeates DB, Gerrity TR, Garrard CS. Characteristics of tracheobronchial deposition and clearance in man. Ann. Occup. Hyg. 26(1-4), 245-257 (1982 (Pubitemid 13232233)
90. Yeates DB, Pitt BR, Spektor DM, Karron GA, Albert RE. Coordination of mucociliary transport in human trachea and intrapulmonary airways. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 51(5), 1057-1064 (1981 (Pubitemid 12235868)
91. Denton R. The rheology of human lung mucus. Ann. NY Acad. Sci. 106, 746-754 (1963
92. Friedman M, Dougherty R, Nelson SR, White RP, Sackner MA, Wanner A. Acute effects of an aerosol hair spray on tracheal mucociliary transport. Am. Rev. Respir. Dis. 116(2), 281-286 (1977 (Pubitemid 8160045)
93. Goodman RM, Yergin BM, Landa JF, Golivanux MH, Sackner MA. Relationship of smoking history and pulmonary function tests to tracheal mucous velocity in nonsmokers, young smokers, ex-smokers, and patients with chronic bronchitis. Am. Rev. Respir. Dis. 117(2), 205-214 (1978 (Pubitemid 8319016)
94. Sackner MA, Landa J, Hirsch J, Zapata A. Pulmonary effects of oxygen breathing. A 6-hour study in normal men. Ann. Intern. Med. 82(1), 40-43 (1975
95. Santacru.R, Landa J, Hirsch J, Sackner MA. Tracheal mucous velocity in normal man and patients with obstructive lung-disease-effects of terbutaline. Am. Rev. Respir. Dis. 109(4), 458-463 (1974
96. Toomes H, Vogt-Moykopf I, Heller WD, Ostertag H. Measurement of mucociliary clearance in smokers and nonsmokers using a bronchoscopic video-Technical method. Lung 159(1), 27-34 (1981 (Pubitemid 11191608)
97. Wanner A, Salathe M, O'Riordan TG. Mucociliary clearance in the airways. Am. J. Respir. Crit. Care 154(6 Pt 1), 1868-1902 (1996 (Pubitemid 26424963)
98. Yeates DB, Gerrity TR, Garrard CS. Particle deposition and clearance in the bronchial tree. Ann. Biomed. Eng. 9(5-6), 577-592 (1981 (Pubitemid 12009513)
99. Donaldson SH, Corcoran TE, Laube BL, Bennett WD. Mucociliary clearance as an outcome measure for cystic fibrosis clinical research. Proc. Am. Thorac. Soc. 4(4), 399-405 (2007 (Pubitemid 47330877)
100. Solhi L, Schonbichler SA, Dünnhaupt S et al. Synthesis and in vitro characterization of a preactivated thiomer via polymerization reaction. Biomacromolecules 13(10), 3054-3063 (2012